These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32492305)

  • 1. Cardiovascular Consequences of Acute Kidney Injury.
    Legrand M; Rossignol P
    N Engl J Med; 2020 Jun; 382(23):2238-2247. PubMed ID: 32492305
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers in acute heart failure.
    Mallick A; Januzzi JL
    Rev Esp Cardiol (Engl Ed); 2015 Jun; 68(6):514-25. PubMed ID: 25911167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of acute heart failure and relevance of biomarkers in elderly patients].
    Ruiz Ortega RA; Manzano L; Montero-Pérez-Barquero M
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():20-5. PubMed ID: 24930079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides, obesity and cardiovascular diseases.
    Castro-Torres Y; Katholi RE
    Rev Assoc Med Bras (1992); 2015; 61(1):19-20. PubMed ID: 25909201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. This patient is not breathing properly: is this COPD, heart failure, or neither?
    Pellicori P; Salekin D; Pan D; Clark AL
    Expert Rev Cardiovasc Ther; 2017 May; 15(5):389-396. PubMed ID: 28395556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natriuretic peptides and their use in clinical practice according to the guidelines of the European Society of Cardiology].
    Stryjewski PJ; Nessler B; Paweł M; Badacz L; Nowak J; Nessler J
    Przegl Lek; 2014; 71(1):33-5. PubMed ID: 24712266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers.
    Dewey CM; Spitler KM; Ponce JM; Hall DD; Grueter CE
    J Am Heart Assoc; 2016 May; 5(6):. PubMed ID: 27247337
    [No Abstract]   [Full Text] [Related]  

  • 8. Natriuretic peptide guided heart failure management.
    Mohammed AA; Januzzi JL
    Curr Clin Pharmacol; 2009 May; 4(2):87-94. PubMed ID: 19442073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary thrombo-embolism presenting as cardiac emergencies.
    Windebank WJ; Boyd G; Moran F
    Scott Med J; 1974 Sep; 19(5):221-8. PubMed ID: 4415391
    [No Abstract]   [Full Text] [Related]  

  • 10. Natriuretic peptides: update on Peptide release, bioactivity, and clinical use.
    Richards AM
    Hypertension; 2007 Jul; 50(1):25-30. PubMed ID: 17452510
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.
    Zachariah D; Olechowski B; Kalra PR
    J Ren Care; 2013 Sep; 39(3):128-39. PubMed ID: 23902278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical application of natriuretic peptides in paediatric cardiology.
    Smith J; Goetze JP; Andersen CB; Vejlstrup N
    Cardiol Young; 2010 Aug; 20(4):353-63. PubMed ID: 20459874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bilateral renal artery stenosis--a cause of acute pulmonary edema].
    Høieggen A; Draganov B; Os I
    Tidsskr Nor Laegeforen; 2001 Jun; 121(15):1789-90. PubMed ID: 11464682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natriuretic peptides as biomarkers for adults with congenital heart disease.
    Nir A; Luchner A; Rein AJ
    Biomark Med; 2012 Dec; 6(6):827-37. PubMed ID: 23227849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in congenital heart disease: do natriuretic peptides hold the key?
    Alonso-Gonzalez R; Dimopoulos K
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):773-84. PubMed ID: 23750686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides: biochemical markers of anthracycline cardiac toxicity?
    Urbanova D; Urban L; Danova K; Simkova I
    Oncol Res; 2008; 17(2):51-8. PubMed ID: 18543606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary effects of OKT3: determinants of hypotension, pulmonary edema, and cardiac dysfunction.
    Costanzo-Nordin MR
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):21-4. PubMed ID: 8465416
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel markers and therapies for patients with acute heart failure and renal dysfunction.
    McCullough PA; Jefferies JL
    Am J Med; 2015 Mar; 128(3):312.e1-22. PubMed ID: 25446297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.
    Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM
    Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving Role of Natriuretic Peptides from Diagnostic Tool to Therapeutic Modality.
    Pagel-Langenickel I
    Adv Exp Med Biol; 2018; 1067():109-131. PubMed ID: 29411335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.